284 reports of this reaction
2.0% of all PRASUGREL HYDROCHLORIDE reports
#11 most reported adverse reaction
THROMBOSIS IN DEVICE is the #11 most commonly reported adverse reaction for PRASUGREL HYDROCHLORIDE, manufactured by Cosette Pharmaceuticals, Inc.. There are 284 FDA adverse event reports linking PRASUGREL HYDROCHLORIDE to THROMBOSIS IN DEVICE. This represents approximately 2.0% of all 14,129 adverse event reports for this drug.
Patients taking PRASUGREL HYDROCHLORIDE who experience thrombosis in device should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
THROMBOSIS IN DEVICE is a less commonly reported adverse event for PRASUGREL HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to thrombosis in device, the following adverse reactions have been reported for PRASUGREL HYDROCHLORIDE:
The following drugs have also been linked to thrombosis in device in FDA adverse event reports:
THROMBOSIS IN DEVICE has been reported as an adverse event in 284 FDA reports for PRASUGREL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
THROMBOSIS IN DEVICE accounts for approximately 2.0% of all adverse event reports for PRASUGREL HYDROCHLORIDE, making it a notable side effect.
If you experience thrombosis in device while taking PRASUGREL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.